The problem of disseminated sclerosis (being the Presidential Address of the Neurological Section, Royal Society of Medicine, October 1946). By Douglas McAlpine. Brain 1946: 69; 233–250.
Do natural killer cells accelerate or prevent autoimmunity in multiple sclerosis?
‘Seronegative’ myasthenia gravis is no longer seronegative
From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases
Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells
Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis
Mitochondrial defects in acute multiple sclerosis lesions
Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis
Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis
Non-communicating syringomyelia: a feature of spinal cord involvement in multiple sclerosis
Intra-cortical connectivity in multiple sclerosis: a neurophysiological approach
Short-latency median-nerve somatosensory-evoked potentials and induced gamma-oscillations in humans
Ripples in the medial temporal lobe are relevant for human memory consolidation
Epileptogenicity of brain structures in human temporal lobe epilepsy: a quantified study from intracerebral EEG
Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1
PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease
fMRI reveals distinct CNS processing during symptomatic and recovered complex regional pain syndrome in children
Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease
Outcome predictors of pallidal stimulation in patients with primary dystonia: the role of disease duration
Sensory deficit in Parkinson's disease: evidence of a cutaneous denervation
The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology
Structural requirements of anti-GD1a antibodies determine their target specificity
IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†
God, theologian and humble neurologist